Director Deals - Shaftesbury PLC (SHB)

Thomas Welton, Executive Director, sold 5,077 shares in the company on the 17th December 2020 at a price of £5.50. The Director now holds 942,007...

Mon, 21/12/2020 - 06:01


Director Deals - Shaftesbury PLC (SHB)

Thomas Welton, Executive Director, has transferred in 10,765 shares in the company on the 17th December 2020 at a price of £0.00. The Director now...

Mon, 21/12/2020 - 06:01


Director Deals - Shaftesbury PLC (SHB)

Thomas Welton, Executive Director, has transferred in 29,618 shares in the company on the 17th December 2020 at a price of £0.00. The Director now...

Mon, 21/12/2020 - 06:01


Slow US start puts FTSE on the back foot, sterling volatile as Brexit uncertainty continues

The FTSE 100 was down 0.5% by the close after a modestly positive open on Wall Street turned negative.

By 4.30pm UK time the S&P...

Fri, 18/12/2020 - 16:32


Director Deals - IQ-AI Limited (IQAI)

Trevor Brown, Chief Executive Officer, sold 800,000 shares in the company on the 16th December 2020 at a price of £0.09. The Director now holds...

Fri, 18/12/2020 - 15:06


Director Deals - IQ-AI Limited (IQAI)

Trevor Brown, Chief Executive Officer, bought 2,762,500 shares in the company on the 16th December 2020 at a price of £0.02. The Director now holds...

Fri, 18/12/2020 - 15:06


Director Deals - IQ-AI Limited (IQAI)

Trevor Brown, Chief Executive Officer, bought 6,540,000 shares in the company on the 16th December 2020 at a price of £0.02. The Director now holds...

Fri, 18/12/2020 - 15:06


Director Deals - IQ-AI Limited (IQAI)

Trevor Brown, Chief Executive Officer, sold 1,100,000 shares in the company on the 16th December 2020 at a price of £0.10. The Director now holds...

Fri, 18/12/2020 - 15:06


Braveheart expects results of Covid-19 test in January

Braveheart Investment Group said work by its investee company Paraytec to develop a Covid-19 test is ‘proceeding at pace’.

Paraytec has acquired purified SARS-CoV2 virus...

Fri, 18/12/2020 - 14:25


4D pharma joins landmark Parkinson's disease study

4D pharma said it has joined the Parkinson's Progression Markers Initiative (PPMI), a study sponsored by The Michael J Fox Foundation (MJFF) to better understand...

Fri, 18/12/2020 - 14:04


Pages